Archive: Addictions

Shelley Starkey

Policy Associate

The Medication Access and Training Expansion (MATE) Act (H.R. 4974) would standardize substance use disorder (SUD) training for providers that prescribe Drug Enforcement Agency (DEA) scheduled medications, such as those used in medication-assisted treatment (MAT). The bipartisan bill, introduced in the House last week, would help to increase access to high-quality care for individuals living […]

Read More |  View Comments

Malka Berro

Policy Associate

Last week, the Drug Enforcement Administration (DEA) officially missed its deadline to submit its plans to Congress on how it will execute a special registration process that would allow providers to prescribe controlled substances via telemedicine. The directive from Congress was passed in last year’s SUPPORT for Patients and Communities Act and was aimed at combatting the opioid crisis by increasing access to medication-assisted treatment (MAT). DEA was given one year from the signing of that law to create and release its plan to initiate this special registration process. While the agency admits it missed the deadline, no plans have yet been announced to comply with the law and finalize the special registration process.

Read More |  View Comments

Shelley Starkey

With just over one week left until the Fiscal Year (FY) 2020 appropriations work is due to avoid a government shutdown, the Senate is still working to finalize its funding bills. Last week, the Senate Appropriations Committee put a pause on their Labor, Health and Human Services, and Education spending discussions over partisan disputes about what should and should not be included in the bill. Although the Committee has yet to discuss or vote on the bill, its draft text and report were publicly posted on Tuesday, a move that is out of the norm until after a full Committee markup.

Read More |  View Comments

Shelley Starkey

The Substance Abuse and Mental Health Services Administration (SAMHSA) has released a proposed rule that would change the way substance use disorder (SUD) treatment records are shared under 42 CFR Part 2. Although the Trump administration does not have the authority to fully align 42 CFR Part 2 with the Health Information Portability and Accountability Act (HIPAA), the administration stated that its proposal aims to “facilitate better coordination of care for substance use disorders, which will also enhance care for opioid use disorder,” according to an official fact sheet on the proposal. Meanwhile, critics expressed concern that the changes to the rule would undermine patient confidentiality and willingness to seek treatment. SAMHSA is accepting public comments on these proposed changes until October 24, 2019.

Read More |  View Comments

Michael Petruzzelli

Director, Federal Policy and Advocacy

New legislation introduced in Congress this week would expand access to telemedicine for mental health and substance use disorder treatment. The Improving Access to Remote Behavioral Health Treatment Act of 2019 (S. 2244/H.R. 4131) would amend regulations for the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 and specifically name community mental health centers and addiction treatment centers as eligible sites to prescribe controlled substances via telemedicine.

Read More |  View Comments

Michael Petruzzelli

Director, Federal Policy and Advocacy

On Tuesday, the House approved a short-term extension of the Certified Community Behavioral Health Clinic (CCBHC) demonstration in Medicaid. The legislation now heads to the White House for President Trump’s review and signature. The bill would extend the program until Friday, September 13, 2019. This extension is yet another legislative victory for the CCBHC program and one on which we will look to build momentum for a long-term extension and expansion in the fall. The National Council thanks Congress and the countless advocates whose work has expanded access to high-quality, community-based treatment through the CCBHC program.

Read More |  View Comments

Rebecca Farley David, VP, Policy & Advocacy

Sara Howe, CEO, Illinois Association for Behavioral Health

The National Council for Behavioral Health Board of Directors has determined to support the bipartisan Mainstreaming Addiction Treatment (MAT) Act (H.R. 2482), which would expand access to medication-assisted treatment, the “gold standard” of addiction treatment when prescribed in conjunction with regular counseling. The National Council thanks the bill authors Reps. Paul Tonko (D-NY), Antonio Delgado (D-NY), Ben Ray Luján (D-NM), Ted Budd (R-NC), Elise Stefanik (R-NY) and Mike Turner (R-OH) for their work on this critical issue.

Read More |  View Comments

Katiri Zuluaga

Manager, State Initiatives

More than 50 percent of incarcerated individuals in the U.S. meet criteria for substance use disorder (SUD), including opioid use disorder (OUD). Last month, Senators Edward Markey (D-MA) and Lisa Murkowski (R-AK) introduced a bill to increase treatment for OUD among incarcerated individuals and address the issue that inmates are 40 times more likely to die from a fatal opioid overdose in the first two weeks following release. The Community Re-Entry through Addiction Treatment to Enhance (CREATE) Opportunities Act (S. 1983) would establish a grant program to provide more medication-assisted treatment (MAT) options while incarcerated and continued access to care upon release.

Read More |  View Comments

Malka Berro

Policy Associate

On Tuesday, the Bipartisan Opioid Task Force held a roundtable discussion on an increasing threat within the opioid epidemic: fentanyl and other synthetic opioids. Synthetic opioids are the leading cause of overdose deaths in the United States, causing over 28,000 deaths in 2017. The roundtable meeting focused on expanding the behavioral health workforce, new criminal justice interventions, innovative pharmacological treatments, and recently proposed legislation.

Read More |  View Comments

Ranjani Sudarsan

Intern, Policy and Practice Improvement

Last week, the Partnership for Medicaid, a nonpartisan advocacy coalition including the National Council, hosted a congressional staff briefing to discuss and unravel some of the most common misconceptions about the Medicaid program and its beneficiaries. The briefing focused specifically on individuals who receive health care via Medicaid and its impact on their lives. The diverse panel of speakers provided an overview of how millions of Americans benefit from the Medicaid program and how Medicaid expansion has led to increases in coverage, access to care and improved health outcomes for beneficiaries.

Read More |  View Comments

Shelley Starkey

The Campus Prevention and Recovery Services for Students Act of 2019 (H.R. 3591), introduced late last month, would help institutions of higher education support students experiencing substance use disorder (SUD). The bill aims to implement evidence-based programs, promote collaboration between schools and state treatment agencies, and encourage integration between primary care, mental health and SUD services in campus-based health centers. The National Council applauds Representatives David Trone (D-MD), Dusty Johnson (R-SD), Chris Pappas (D-NH), John Joyce (R-PA), Lucy McBath (D-GA), and Michael Guest (R-MS) for their leadership on this issue.

Read More |  View Comments

Shelley Starkey

This week, a group of 95 Democrats in the House and Senate re-introduced a bill that would invest $100 billion in federal funds over ten years to better address the opioid overdose epidemic, which took almost 48,000 American lives in 2017. The Comprehensive Addiction Resources Emergency (CARE) Act (S. 1365/H.R. 2569) includes provisions to strengthen standards for recovery residences, establish new grant programs to help individuals living with addictions find or maintain employment, and incentivize states to cover the full range of addiction services in their Medicaid programs. The National Council thanks the CARE Act’s sponsors for their work to provide desperately needed resources that will expand addiction treatment capacity nationwide.

Read More |  View Comments

Shelley Starkey

The Office of National Drug Control Policy (ONDCP), a component of the White House responsible for coordinating the nation’s response to drug-related issues such as the opioid overdose epidemic, released its Performance Reporting System last week, which established nine measurable goals and objectives meant to be achieved by 2022. The goals include reducing the number of drug overdose deaths, increasing prescriber education on best practices and clinical guidelines, and expanding access to evidence-based addiction treatment options.

Read More |  View Comments

Katiri Zuluaga

Manager, State Initiatives

A bipartisan piece of legislation has been introduced in the House that would remove restrictions on health providers to prescribe buprenorphine, a medication proven effective in treating opioid use disorder. The Mainstreaming Addiction Treatment Act (H.R.2482) would eliminate the requirement for medical providers to obtain a waiver from the Drug Enforcement Administration (DEA) to treat opioid use disorder with buprenorphine or any other Schedule III, IV or V drug. Currently, practitioners must apply for the waiver in order to prescribe buprenorphine specifically to treat addiction, even though they may be able to prescribe the medication for other reasons.

Read More |  View Comments

Stephanie Pellitt

, National Council for Behavioral Health

On Tuesday, the appropriations subcommittee that covers health care programs approved funding levels for federal health spending for Fiscal Year (FY) 2020. As expected, the bill largely ignores proposed cuts from President Trump’s budget and assumes that Congress will reach a deal to avoid upcoming budget caps. As currently written, the Labor, Health and Human Services, Education and Related Agencies (Labor-HHS) appropriations bill would prioritize efforts to address the opioid crisis and increase medical research.

Read More |  View Comments

Stephanie Pellitt

, National Council for Behavioral Health

Last week, the National Council provided official comments to the Substance Abuse and Mental Health Services Administration (SAMHSA) on the agency’s proposed Recovery Housing Guidelines. The guidelines are the result of requirements included in the SUPPORT Act of 2018, a wide-ranging opioid package, for the federal government to identify and disseminate best practices for operating recovery housing. While the guidance is intended to help states increase the availability of quality recovery housing, the National Council raised numerous concerns that the guidance would instead reduce access to recovery housing and undermine existing recovery housing standards and certification programs.

Read More |  View Comments

Shelley Starkey

Last week, a bipartisan group of lawmakers reintroduced a bill in both the House and the Senate that would amend federal laws related to the sharing of substance use disorder (SUD) treatment records. The bills (S. 1012/H.R. 2062) would change 42 CFR Part 2, the section of the federal code related to this issue, to align it with the Health Information Portability and Accountability Act (HIPAA). Identical bills have been introduced in previous sessions of Congress but have subsequently failed to pass due to opposition from privacy advocacy groups and a handful of legislators.

Read More |  View Comments

Stephanie Pellitt

, National Council for Behavioral Health

Addiction workforce advocates presented on the Hill this week as part of a congressional staff briefing exploring opportunities for Congress to better equip front-line providers to prevent and treat opioid and other addictions. The hearing featured testimony from Mary-Catherine Bohan, representing a Certified Community Behavioral Health Clinic (CCBHC) from New Jersey, who shared how the CCBHC model is transforming her clinic’s ability to hire addiction treatment professionals and serve more patients.

Read More |  View Comments

Shelley Starkey

The Office of National Drug Control Policy (ONDCP), a component of the White House responsible for coordinating the nation’s response to drug-related issues such as the opioid overdose epidemic, last week released its first National Drug Control Strategy since President Trump took office. The strategy calls on federal agencies to focus their efforts on preventing individuals from initiating use of illicit drugs, providing adequate evidence-based treatment for individuals living with addiction, and reducing the availability of illicit drugs via law enforcement activities.

Read More |  View Comments

Stephanie Pellitt

, National Council for Behavioral Health

The Health Resources and Services Administration (HRSA) is currently accepting clinician applications for the National Health Service Corps (NHSC) Substance Use Disorder Workforce Loan Repayment Program. The program offers up to $75,000 in student loan repayment for clinicians who work at least three years providing substance use treatment at an approved site. Applicants that have a DATA-2000 waiver to prescribe buprenorphine to treat opioid use disorder, work in an opioid treatment program or are licensed or certified in substance use interventions, will receive priority. Applications will be accepted on or before February 21, 2019.

Read More |  View Comments